Neurosearch denies share manipulation charges

COPENHAGEN Wed May 23, 2012 3:24pm IST

Related Topics

Stocks

   

COPENHAGEN (Reuters) - Danish biopharma firm Neurosearch A/S said on Wednesday charges of share price manipulation had been filed against it, but it denied the allegations and said it was working with the authorities to clear up the matter.

Neurosearch said the charges were related to an announcement in February 2010 in which the management of the company reported top-line results from a Phase III study with its Huntington's disease drug candidate Huntexil and then two months later reassessed and corrected the data in a new announcement.

"On the present basis, Neurosearch is denying the charges and is collaborating fully with the authorities in order to resolve the matter," the company said in a statement.

(Reporting by John Acher)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Ebola Outbreak

Diabetes And TB

Diabetes And TB

Experts sound alarm as diabetes fuels cases of TB.  Full Article 

Microsoft Band

Microsoft Band

Microsoft launches wearable fitness device for $199.  Full Article 

Long-Term Effect

Long-Term Effect

Having controlling parents may affect later relationships.  Full Article 

Exercise Trend

Exercise Trend

Paddleboard yoga stands venerable practice on its head, on water.  Full Article 

Spike In Polio Cases

Spike In Polio Cases

'Disastrous' health campaign feeds Pakistan's worrying polio spike.  Full Article 

Factbox On GM Crops

Factbox On GM Crops

GMO crops have history of controversy.  Factbox 

Teal Pumpkin Project

Teal Pumpkin Project

Painted pumpkins raising awareness about food allergies.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage